Sixth Element Capital Investor

Sixth Element Capital is currently managing its first fund: the £70m CRT Pioneer Fund (CPF) to create the future of cancer therapy and diagnosis. CPF invests in oncology focused assets and companies and has a proprietary relationship with Cancer Research Technology (CRT). CPF's investors are the European Investment Fund and Syncona.

Invests into
Industry: Preventive Medicine
Headquarters: Berkhamsted, Buckinghamshire, United Kingdom
Founded Date: Undisclosed
Employees Number: Undisclosed
Funding Status: N/A
Investor Type: Venture Capital
Investment Stage: Early Stage Venture, Venture
Number Of Exits: N/A

Visit Website
Register and Claim Ownership